Identification of Mutations in the C-mpl Gene in Congenital Amegakaryocytic Thrombocytopenia

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1999 Mar 17

PMID 10077649

Citations 77

Authors

K Ihara

E Ishii

M Eguchi

H Takada

A Suminoe

R A GOOD

T Hara

Affiliations

Soon will be listed here.

Abstract

Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare disorder expressed in infancy and characterized by isolated thrombocytopenia and megakaryocytopenia with no physical anomalies. Our previous hematological analysis indicated similarities between human CAMT and murine c-mpl (thrombopoietin receptor) deficiency. Because the c-mpl gene was considered as one of the candidate genes for this disorder, we analyzed the genomic sequence of the c-mpl gene of a 10-year-old Japanese girl with CAMT. We detected two heterozygous point mutations: a C-to-T transition at the cDNA nucleotide position 556 (Q186X) in exon 4 and a single nucleotide deletion of thymine at position 1,499 (1,499 delT) in exon 10. Both mutations were predicted to result in a prematurely terminated c-Mpl protein, which, if translated, lacks all intracellular domains essential for signal transduction. Each of the mutations was segregated from the patient's parents. Accordingly, the patient was a compound heterozygote for two mutations of the c-mpl gene, each derived from one of the parents. The present study suggests that at least a certain type of CAMT is caused by the c-mpl mutation, which disrupts the function of thrombopoietin receptor.

Citing Articles

LMAN1 serves as a cargo receptor for thrombopoietin.

Everett L, Lin Z, Friedman A, Tang V, Myers G, Balbin-Cuesta G JCI Insight. 2024; 9(24).

PMID: 39499573 PMC: 11665562. DOI: 10.1172/jci.insight.175704.

A Systematic Review and Meta-Analysis of Eltrombopag Efficacy Combined With Immunosuppressive Drugs in Treatment of Severe Aplastic Anemia.

Illango J, Seffah K, Naveen N, Paudel Y, Patel A, Pachchipulusu V Cureus. 2024; 16(8):e65970.

PMID: 39221321 PMC: 11365712. DOI: 10.7759/cureus.65970.

Genistin: A Novel Estrogen Analogue Targeting ERβ to Alleviate Thrombocytopenia.

Tang X, Liao R, Zhou L, Yi T, Ran M, Luo J Int J Biol Sci. 2024; 20(6):2236-2260.

PMID: 38617546 PMC: 11008259. DOI: 10.7150/ijbs.90483.

Fetal and neonatal outcomes of posterior fossa anomalies: a retrospective cohort study.

Alsehli H, Alshahrani S, Alzahrani S, Ababneh F, Alharbi N, Alarfaj N Sci Rep. 2024; 14(1):8411.

PMID: 38600369 PMC: 11006671. DOI: 10.1038/s41598-024-59163-8.

Deciphering the differential impact of thrombopoietin/MPL signaling on hematopoietic stem/progenitor cell function in bone marrow and spleen.

Lee S, Zhan H Stem Cell Reports. 2024; 19(2):211-223.

PMID: 38215758 PMC: 10874852. DOI: 10.1016/j.stemcr.2023.12.004.

References

Gurney A, de Sauvage F, Moore M . Thrombocytopenia in c-mpl-deficient mice. Science. 1994; 265(5177):1445-7. DOI: 10.1126/science.8073287. View

Kaushansky K, Broudy V, Lin N, Jorgensen M, McCarty J, Fox N . Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A. 1995; 92(8):3234-8. PMC: 42140. DOI: 10.1073/pnas.92.8.3234. View

Columbyova L, Loda M, Scadden D . Thrombopoietin receptor expression in human cancer cell lines and primary tissues. Cancer Res. 1995; 55(16):3509-12. View

Hoyeraal H, Lamvik J, MOE P . Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers. Acta Paediatr Scand. 1970; 59(2):185-91. DOI: 10.1111/j.1651-2227.1970.tb08986.x. View

Hedberg V, Lipton J . Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol. 1988; 10(1):51-64. DOI: 10.1097/00043426-198821000-00010. View

Freedman M, Estrov Z . Congenital amegakaryocytic thrombocytopenia: an intrinsic hematopoietic stem cell defect. Am J Pediatr Hematol Oncol. 1990; 12(2):225-30. View

Vigon I, Mornon J, Cocault L, Mitjavila M, Tambourin P, Gisselbrecht S . Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A. 1992; 89(12):5640-4. PMC: 49348. DOI: 10.1073/pnas.89.12.5640. View

Sachs A . Messenger RNA degradation in eukaryotes. Cell. 1993; 74(3):413-21. DOI: 10.1016/0092-8674(93)80043-e. View

de Sauvage F, Hass P, Spencer S, Malloy B, Gurney A, Spencer S . Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369(6481):533-8. DOI: 10.1038/369533a0. View

10.

Lok S, Kaushansky K, Holly R, Kuijper J, Oort P, Grant F . Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994; 369(6481):565-8. DOI: 10.1038/369565a0. View

11.

BARTLEY T, Bogenberger J, Hunt P, Li Y, Lu H, Martin F . Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 1994; 77(7):1117-24. DOI: 10.1016/0092-8674(94)90450-2. View

12.

Mignotte V, Vigon I, Boucher de Crevecoeur E, Romeo P, Lemarchandel V, Chretien S . Structure and transcription of the human c-mpl gene (MPL). Genomics. 1994; 20(1):5-12. DOI: 10.1006/geno.1994.1120. View

13.

Alexander W, Roberts A, Nicola N, Li R, Metcalf D . Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996; 87(6):2162-70. View

14.

Broxmeyer H, Luoh S, Cooper S, Peng J, BURSTEIN S, Moore M . Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood. 1996; 88(3):803-8. View

15.

Muraoka K, Ishii E, Tsuji K, Yamamoto S, Yamaguchi H, Hara T . Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia. Br J Haematol. 1997; 96(2):287-92. DOI: 10.1046/j.1365-2141.1997.d01-2028.x. View

16.

Takatoku M, Kametaka M, Shimizu R, Miura Y, Komatsu N . Identification of functional domains of the human thrombopoietin receptor required for growth and differentiation of megakaryocytic cells. J Biol Chem. 1997; 272(11):7259-63. DOI: 10.1074/jbc.272.11.7259. View

17.

Ballmaier M, Schulze H, Strauss G, Cherkaoui K, Wittner N, Lynen S . Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood. 1997; 90(2):612-9. View

18.

Kimura S, Roberts A, Metcalf D, Alexander W . Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A. 1998; 95(3):1195-200. PMC: 18717. DOI: 10.1073/pnas.95.3.1195. View

19.

Strippoli P, Savoia A, Iolascon A, Tonelli R, Savino M, Giordano P . Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR). Br J Haematol. 1998; 103(2):311-4. DOI: 10.1046/j.1365-2141.1998.00991.x. View